A Randomised, Open-label, Multi-center, Angiographic Trial to Compare the Efficacy and Safety of Single Bolus of Tenecteplase (Metalyse (R)) With Accelerated Infusion of Alteplase in Asian Patients With Acute Myocardial Infarction

Trial Profile

A Randomised, Open-label, Multi-center, Angiographic Trial to Compare the Efficacy and Safety of Single Bolus of Tenecteplase (Metalyse (R)) With Accelerated Infusion of Alteplase in Asian Patients With Acute Myocardial Infarction

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Oct 2013

At a glance

  • Drugs Alteplase; Tenecteplase
  • Indications Myocardial infarction
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Oct 2013 Planned number of patients changed from 240 to 270 as reported by ClinicalTrials.gov.
    • 20 Dec 2007 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top